Antibacterial and antifungal activities of polyketide metabolite from marine Streptomyces sp. AP-123 and its cytotoxic effect

Chemosphere

Volumn 90, Issue 2, 2013, Pages 479-487

  Arasu, Mariadhas Valan ^a,c   Duraipandiyan, Veeramuthu ^b,c   Ignacimuthu, Savarimuthu ^c  

^a Chungnam National University   (South Korea)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c LOYOLA COLLEGE   (India)

Author keywords

16S rDNA; Antimicrobial activity; Cytotoxic activity; Ketoacyl synthase gene; Minimum inhibitory concentration; Streptomyces sp.

Indexed keywords

AMINO ACIDS; ANTIBIOTICS; ASPERGILLUS; BACTERIOLOGY; CELL CULTURE; CHROMATOGRAPHIC ANALYSIS; CLONE CELLS; DIAGNOSIS; ESCHERICHIA COLI; KETONES; METABOLITES; MICROWAVE INTEGRATED CIRCUITS;

16S RDNA; ANTI-MICROBIAL ACTIVITY; CYTOTOXIC ACTIVITIES; MINIMUM INHIBITORY CONCENTRATION; STREPTOMYCES SP; SYNTHASE GENE;

GENES;

ACETIC ACID ETHYL ESTER; DIAMINOPIMELIC ACID; DNA 16S; FLUCONAZOLE; GLYCINE; HEXANE; KETOCONAZOLE; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; POLYKETIDE; POLYKETIDE SYNTHASE; SPARFLOXACIN; STREPTOMYCIN;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOTECHNOLOGY; CHEMICAL COMPOSITION; CONCENTRATION (COMPOSITION); ECOTOXICOLOGY; ESTER; EXTRACTION METHOD; GENE EXPRESSION; GENETIC ANALYSIS; INHIBITOR; MARINE ENVIRONMENT; MEDICINE; METABOLITE; POLYMER;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; BIOINFORMATICS; BROTH DILUTION; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; CARCINOMA CELL; CELL WALL; CONTROLLED STUDY; CYTOTOXICITY; EPIDERMOPHYTON FLOCCOSUM; ESCHERICHIA COLI; FUNGAL GENE; FUNGAL STRAIN; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; INDIA; INFRARED SPECTROSCOPY; LARYNX CARCINOMA; MARINE SPECIES; METABOLITE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLOGENY; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOMYCES; STREPTOMYCES FILIPINENSIS; STREPTOMYCES FLAVOGRISEUS; STREPTOMYCES MACROMOMYCETICUS; STREPTOMYCES NODOSUS; TRICHOPHYTON; VERO CELL;

ANDHRA PRADESH; INDIA;

ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANDIDA ALBICANS; CERCOPITHECUS AETHIOPS; ESCHERICHIA COLI; FUNGI; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOMYCES; STREPTOMYCES FLAVOGRISEUS; STREPTOMYCES SP.;

EID: 84869871814     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2012.08.006     Document Type: Article

References (53)

1. Abbanat D., Macielag M., Bush K. Novel antibacterial agents for the treatment of serious gram-positive infections. Expert. Opin. Inv. Drug. 2003, 12(3):379-399.
2. Banskota A.H., McAlpine J.B., Sorensen D., Aouidate M., Piraee M. Isolation and identification of three new 5- alkenyl-3, 3(2H)-furanones from two Streptomyces species using a genome screening approach. J. Antibiot. 2006, 59:168-176.
3. Bauer A.W., Kirby W.M.M., Sherris J.C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 1996, 45:493-496.
4. Becker B., Lechevalier M.P., Gordon R.E., Lechevalier H.A. Rapid differentiation between Nocardia and Streptomyces by paper chromatography of whole cell hydrolysate. Appl. Microbiol. 1964, 12:421-424.
5. Borenfreund E., Babich H., Martin-Alguacil N. Comparison of two in vitro cytotoxicity assays: the neutral red (NR) and tetrozolium (MTT) tests. Toxicol. Vitro 1988, 2(1):1-6.
6. Butler M.S., Buss A.D. Natural products - the future scaffolds for novel antibiotics?. Biochem. Pharmacol. 2006, 71:919-929.
7. Coates A.R.M., Hu Y. Novel approaches to developing new antibiotics for bacterial infections. Brit. J. Pharmacol. 2007, 152:1147-1154.
8. Demain A.L., Elander R.P. The β-lactam antibiotics: past, present, and future. Antonie Van Leeuwenhoek 1999, 75:5-19.
9. Donadio S., Brandi L., Monciardini P., Sosio M., Gualerzi C.O. Novel assays and novel strains - promising routes to new antibiotics. Expert. Opin. Drug. Dis. 2007, 2:789-798.
10. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985, 39:783-791.
11. Fenical W., Jensen P.R. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat. Chem. Biol. 2006, 2:666-673.
12. Gandhimathi R., Arunkumar M., Selvin J., Thangavelu T., Sivaramakrishnan S., Kiran G.S. Antimicrobial potential of sponge associated marine actinomycetes. J. Mycol. Med. 2008, 18:16-22.
13. Gorajana A., Karuda B.V., Peela S., Jangam P., Vinjamuri S., Poluri E., Zeeck A. 1-Hydroxy-1-norresistomycin, a new cytotoxic compound from marine actinomycetes, Streptomyces chibaensis AUB1/7. J. Antibiot. 2005, 58:526-529.
14. Gunatilaka A.A.L. Natural products from plant-associated microorganisms: distribution, structural diversity, bioactivity, and implications of their occurrence. J. Nat. Prod. 2006, 69:509-526.
15. Hacene H., Daoudi H., Bhatnagar T., Baratti J.C., Lefebvre G. A new aminoglycosidase anti Pseudomonas antibiotic produced by a new strain of Spirillosora. Microbiol. 2000, 102:69.
16. Jeong M.S., Park J.S., Song S.H., Jang S.B. Characterization of antibacterial nanoparticles from the Scallop. P. yessoensis. Biosci. Biotechnol. Biochem. 2007, 71:2242-2247.
17. Kock I., Maskey R.P., Biabani M.A., Helmke E., Laatsch H. 1-Hydroxy-1-norresistomycin and resistoflavin methyl ether: new antibiotics from marine-derived Streptomycetes. J. Antibiot. 2005, 58:530-534.
18. Lechevalier H.A., Lechevalier M.P. A critical evaluation of the genera of aerobic actinomycete. The Actinomycetes 1970, 393-405. Gustav F Ischer-Verlag, Jena. H. Prauser (Ed.).
19. Lechevalier H.A., Willium S.T., Sharpe M.E., Holt J.G. The Actinomycetes: a practical guide to genetic identification of actinomycetes. Bergy's Manual of Determinative Bacteriology 1989, The Williams & Wilkins Co., Baltimore, Maryland, USA, pp. 2344-3330.
20. Lee J.Y., Hwang B.K. Diversity of antifungal actinomycetes in various vegetative soils of Korea. Can. J. Microbiol. 2002, 48:407-417.
21. Locci R. Streptomyces and related genera. Bergeys Manual of Systematic Bacteriology 1989, Williams & Wilkins Company, Baltimore, pp. 2344-2508. fourth ed.
22. Lockwood N.A., Mayo K.H. The future for antibiotics: bacterial membrane disintegrators. Drug Future. 2003, 28:911-923.
23. Luzhetskyy A., Pelzer S., Bechthold A. The future of natural products as a source of new antibiotics. Curr. Opin. Invest. Dr. 2007, 8:608-613.
24. Maestro B., Sanz J.M. Novel approaches to fight Streptococcus pneumoniae. Recent Pat. Antiinfect. Drug Discov. 2007, 2(3):188-196.
25. Maldonado L.A., Fenical W., Jensen P.R., Kauffman C.A., Mincer T.J., Wrad A.C., Bull A.T., Goodfellow M. Salinispora arenicolaen. nov., and Salinispora tropica nov., obligate marine actinomycetes belonging to the family Micromonosporaceae. Int. J. Syst. Evol. Microbiol. 2005, 55:1759-1766.
26. Maruyama H.B., Suhara Y., Suzuki-Watanable, Maeshima Y., Shimizu M. A new antibiotic, fumaramidmycin-I production, biological properties and characterization of producer strain. J. Antibiot. 1975, 28:636-647.
27. Metsa K.M., Halo L., Munukka E., Hakala J., Mantsala P. Molecular evolution of aromatic polyketides and comparative sequence analysis of polyketide ketosynthase and 16S ribosomal DNA genes from various Streptomyces species. Appl. Environ. Microbiol. 2002, 68:4472-4479.
28. Mikko M.K., Virpi S., Laura H., Anne H., Juha H., Pekka M., Kristiina Y. An efficient approach for screening minimal PKS genes from Streptomyces. FEMS. Microbiol. Lett. 1999, 180:1-6.
29. Mukherjee G., Sen S.K. Characterization and identification of chitinase producing Streptomyces venezulae P10. Indian. J. Exp. Biol. 2004, 42:541-544.
30. National Committee for Clinical Laboratory Standards (NCCLS), 1999. Document M31-A performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, approved standard NCCLS, Villanova, p. 57.
31. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25years. J. Nat. Prod. 2007, 70:461-477.
32. Ouhdouch Y., Barakate M., Finanse C. Actinomycetes of Moroccan habitats: isolation and screening for antifungal activities. Eur. J. Soil. Biol. 2001, 37:69-74.
33. Prabavathy V.R., Mathivanan N., Murugesan K. Control of blast and sheath blight diseases of rice using antifungal metabolites produced by Streptomyces sp. PM5. Biol. Control. 2006, 39:313-319.
34. Robinson J.A. Polyketide synthase complexes: their structure and function in antibiotic biosynthesis. Philos. Trans. R. Soc. B 1991, 332:107-114.
35. Roes L.M., Meyer P.R. Streptomyces pharetrae sp. nov., isolated from soil from the semi-arid Karoo region. Syst. Appl. Microbiol. 2005, 28:488-493.
36. Saadoun I., Al-Momani F., Malkawi H.I., Mohammad M.J. Isolation, identification and analysis of antibacterial activity of soil Streptomycetes isolates from North Jordan. Microbios 1999, 100(395):41.
37. Saadoun I., Gharaibeh R. The Streptomyces flora of badia region of jordan and its potential as a source of antibiotics active against antibiotic-resistant bacteria. J. Arid Environ. 2003, 53(3):365-371.
38. Sahin N. Antimicrobial activity of Streptomyces species against mushroom blotch disease pathogen. J. Basic. Microbiol. 2005, 45:64-71.
39. Sharma S.L., Pant A. Crude oil degradation by marine actinomycetes Rhodococcus sp. Indian J. Mar. Sci. 2001, 30:146-150.
40. Shirling J.L., Gottlieb D. Methods for characterization of Streptomyces species. Int. J. Syst. Bacterial. 1966, 16:313-340.
41. Singh S.B., Barret J.F. Empirical antibacterial drug discovery - foundation in natural products. Biochem. Pharmacol. 2006, 71:1006-1015.
42. Sofia M.J., Boldi A.M. In search of novel antibiotics using a natural product template approach combinatorial synthesis of natural product-based libraries 2006, CRC Press, LLC, Boca Raton, pp. 185-207.
43. Staneck J.L., Roberts G.D. Simplified approach to identification of aerobic actinomycetes by thin layer chromatography. Appl. Microbiol. 1974, 28:226-231.
44. Staunton J., Weissman K.J. Polyketide biosynthesis: a millennium review. Nat. Prod. Rep. 2001, 18:380-416.
45. Sujatha P., Bapi R.K.V.V.S.N., Ramana T. Studies on a new marine Streptomycete BT-408 producing polyketide antibiotic SBR-22 effective against methicillin resistant Staphylococcus aureus. Microbiol. Res. 2005, 160:119-126.
46. Tamura K., Nei M., Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. USA 2004, 101:11030-11035.
47. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28(10):2731-2739.
48. Tresner H.D., Davies M.C., Backus E.J. Electron microscopy of Streptomyces spore morphology and its role in species differentiation. J. Bacteriol. 1961, 81:70-80.
49. Valan A.M., Asha K.R.T., Duraipandiyan V., Ignacimuthu S., Agastian P. Characterization and phylogenetic analysis of novel polyene type antimicrobial metabolite producing actinomycetes from marine sediments: Bay of Bengal India. Asian Pac. J. Trop. Biomed. 2012, 2(10):803-810.
50. Valan A.M., Duraipandiyan V., Agastian P., Ignacimuthu S. Antimicrobial activity of Streptomyces spp. ERI-26 recovered from Western Ghats of Tamil Nadu. J. Mycol. Med. 2008, 18:147-153.
51. Williams S.T., Cross T. Isolation, purification, cultivation and preservation of actinomycetes. Methods. Microbiol. 1971, 4:295-333.
52. Williams S.T., Goodfellow M., Alderson G., Wellington E.M.H., Sneath P.H.A., Sackin M. Numerical classification of Streptomyces and related genera. J. Gen. Microbiol. 1983, 129:1743-1813.
53. Yilmaz O., Young P.A., Lamont R.J., Kenny G.E. Gingival epithelial cell signalling and cytoskeletal responses to Porphyromonas gingivalis invasion. Microbiology 2003, 149:2417-2426.